leisure time -WSS

leisure time

author：focus 2025-10-01 12:54:58 - browse：36

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

Physician groups backed by private equity giant lobby on mergers

Trump indictment: Who are the 'co

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

National panel will explore requiring free Covid tests

NIH launches clinical trials and new research office for long Covid

entertainment

leisure time

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

A new initiative will help leaders fight the next pandemic

Anesthesiologist group: stop taking Ozempic before surgery

Infectious disease expert Jeanne Marrazzo assumes Fauci role

How one medical school became remarkably diverse

Senators tussle over abortion against the backdrop of a presidential campaign

Activists slam private health insurers over coverage restrictions

STAT wants to know your pick for a great summer read or listen

Trump demands the U.S. pay no more for drugs than other countries … again

Physician groups backed by private equity giant lobby on mergers

leisure time

What to expect as Trump is arraigned on his Jan 6. indictment

The high personal cost of affirmative action for Black doctors

5 important ways Henrietta Lacks changed medical science

Scientists inch closer to single

National panel will explore requiring free Covid tests

National panel will explore requiring free Covid tests

focus

hotspot

knowledge

explore